The Rise and Fall of ICI: A Corporate Journey

This chapter examines ICI's evolution from a pharmacological leader to its decline and acquisition, highlighting the pivotal role of James Black in drug discovery. It critiques the shift towards shareholder-centric business models, advocating for a renewed focus on stakeholder value and broader corporate responsibility.